• 868 - COVID-19 Convalescent Plasma: From Emergency to Everyday

  • Mar 13 2025
  • Duración: 12 m
  • Podcast

868 - COVID-19 Convalescent Plasma: From Emergency to Everyday

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • About this episode: In the early days of the COVID-19 pandemic when there were no vaccines or treatments, convalescent plasma—antibody-containing blood from people who recovered from COVID—saved countless lives through Emergency Use Authorization. In this episode: special guest host Thomas Locke of MMI Monthly: From Bench To Breakthrough discusses the evolution of CCP therapy, from emergency use during the pandemic to now, nearly five years later, crossing the finish line with recent FDA approval as a potential treatment for immunocompromised patients. Guest: is a professor in and a researcher at the . Host: Thomas Locke is the host of and , podcasts from the department of at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: d—Johns Hopkins Bloomberg School of Public Health —The Hub —The Wall Street Journal (Opinion) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us or . Follow us: Here's our Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
    Más Menos
Más Menos

Lo que los oyentes dicen sobre 868 - COVID-19 Convalescent Plasma: From Emergency to Everyday

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles